Showing 7,462 news articles about Health services & systems

Filters Content type: Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

Clinical trials

Failed Trial in Africa Raises Questions About How to Test HIV Drugs

Editor's pick
New York Times
5 February 2015
Pharmaceutical industry

GlaxoSmithKline seeks advice on floating HIV division

Editor's pick
The Guardian
5 February 2015
Hepatitis C treatment

What the 'Shocking' Gilead Discounts on its Hepatitis C Drugs Will Mean

Editor's pick
Wall Street Journal (blog)
5 February 2015
Drug-resistant TB

Access sought to tuberculosis drug from nutraceutical company

Editor's pick
Nature Medicine
5 February 2015
Hepatitis C treatment

Sales of Sovaldi, New Gilead Hepatitis C Drug, Soar to $10.3 Billion

Editor's pick
New York Times
5 February 2015
Hepatitis B

Hepatitis Quest Moves From C to B Under Former Gilead Executives

Editor's pick
Bloomberg
5 February 2015
New & experimental hepatitis C treatment

Merck says hepatitis C drugs to lose breakthrough status

Editor's pick
Reuters
5 February 2015
Improving HIV care

HIV science and treatment knowledge can end AIDS epidemic in the US

Editor's pick
News Medical
4 February 2015
Finance & funding

How Hepatitis C Is Shining A Light On Critical Gaps In Payment Reform

Editor's pick
Health Affairs (blog)
4 February 2015
Sexually transmitted infections tests & treatment

S.T.D. Care for Two

Editor's pick
New York Times
3 February 2015
Access to healthcare

Activist Strategies for Increasing Access to HCV Treatment in Low- and Middle-Income Countries

Editor's pick
TAG
3 February 2015
Pharmaceutical industry

AbbVie Inc stock drops after expectations for Viekira Pak fall short

Editor's pick
Bidness Etc
2 February 2015
Access to healthcare

Hepatitis C drug access: Europe is the new Africa

Editor's pick
HIV i-Base
30 January 2015
Access to healthcare

Petition: Equitable access to HCV drugs

Editor's pick
Petitionbuzz
30 January 2015
New & experimental HIV treatments

PREZCOBIX™ (darunavir/cobicistat) approved in the U.S. for the treatment of adults living with HIV-1

Editor's pick
Janssen press release
30 January 2015
New & experimental HIV treatments

U.S. Food and Drug Administration approves Bristol-Myers Squibb’s Evotaz™ (atazanavir and cobicistat) for the treatment of HIV-1 infection in adults

Editor's pick
Bristol-Myers Squibb press release
30 January 2015
Access to healthcare

Study Finds HIV Drugs Priced Out of Reach

Editor's pick
New York Times
29 January 2015
Access to healthcare

Russia may face shortage of anti-AIDS drugs in 2015

Editor's pick
EATG
29 January 2015
Transmission & prevention

European Advocates Engage with Biomedical Prevention

Editor's pick
AVAC
28 January 2015
Access to healthcare

MSF response to Gilead announcement on inclusion of hepatitis C drug GS-5816 in voluntary licence

Editor's pick
Médecins Sans Frontières press release
27 January 2015
New & experimental hepatitis C treatment

Gilead Expands Hepatitis C Generic Licensing Agreements to Include Investigational Pan-Genotypic Agent

Editor's pick
Gilead press release
27 January 2015
HIV prevention policy

Bill Gates Predicts Two Miracles for AIDS Relief by 2030

Editor's pick
Bloomberg
26 January 2015
Pharmaceutical industry

Merck (MRK) Receives Positive CHMP Opinion for Dutrebis as HIV 1 Treatment

Editor's pick
Street Insider
26 January 2015
Hepatitis C treatment

German insurers win discounts on Gilead's Sovaldi

Editor's pick
Yahoo News
26 January 2015